Unexpected Histological Finding of Diffuse Large B-CellLymphoma in a Patient with Long-standing Goiter andHashimoto's Thyroiditis: A Case Report
DOI:
https://doi.org/10.66266/inajemd.v2i2.59Abstract
Background: Primary thyroid lymphoma (PTL) is an uncommon malignancy, comprising less than 5% of all thyroid cancers. Hashimoto's thyroiditis (HT) is the most significant risk factor, increasing the risk of developing PTL by 40 to 80 times. Diffuse large B-cell lymphoma (DLBCL) is the most prevalent and aggressive histological subtype, accounting for over 50% of PTL cases. The diagnosis is challenging, as the clinical and sonographic features of PTL can mimic benign thyroiditis.
Case Presentation:
A 60-year-old female with a three-year history of a progressively enlarging goiter and worsening compressive symptoms presented for surgical evaluation. Initial investigations revealed severe
hypothyroidism and ultrasound findings of a nodular goiter with features of thyroiditis (TI-RADS 3). She underwent a total thyroidectomy for symptomatic relief. Postoperative histopathology
unexpectedly revealed a DLBCL, confirmed by CD20 positivity, coexisting with a background of classic HT. The patient was subsequently treated with six cycles of R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) chemoimmunotherapy and achieved a complete clinical and radiological response.
Conclusion:
This case underscores the diagnostic challenge PTL presents, particularly in patients with preexisting HT. A high index of suspicion is crucial for clinicians managing HT patients who present with a rapidly enlarging goiter or worsening compressive symptoms. While fine-needle aspiration has limitations, definitive diagnosis often requires a core needle or excisional biopsy to differentiate neoplastic infiltration from the benign lymphocytic infiltrate of HT.
Downloads
References
1. Ghafouri AM, Alzaidi S, Al-Kaabi BB, et al.
Thyroid B-Cell Lymphoma in the Background
of Hashimoto's Thyroiditis: A Case Report and
Literature Review. Cureus. 2024;16(3):e57359.
2. Vita O, Dema A, Barna R, et al. Primary Thyroid
Lymphoma: A Retrospective-Observational
Study in a Single Institutional Center. Medicina
(Kaunas). 2024;60(3):476.
3. Travaglino A, Pace M, Varricchio S, et al.
Hashimoto Thyroiditis in Primary Thyroid Non-
Hodgkin Lymphoma: A Systematic Review and
Meta-Analysis. Am J Clin Pathol. 2020;153(2):156-
164.
4. Holm LE, Blomgren H, Löwhagen T. Cancer risks
in patients with chronic lymphocytic thyroiditis. N
Engl J Med. 1985;312(10):601-604.
5. Otsuka Y, Yasuda M, Tokumasu K, Hasegawa K,
Otsuka F. Hashimoto's thyroiditis and primary
thyroid lymphoma. QJM. 2020;113(9):691-692.
6. Derringer GA, Thompson LD, Frommelt RA, et
al. Malignant lymphoma of the thyroid gland: a
clinicopathologic study of 108 cases. Am J Surg
Pathol. 2000;24(5):623-639.
7. Aggarwal T, Reyes S, Glitza Oliva IC, Korytnaya E.
Thyroid Lymphoma In A Patient With Hashimoto's
Thyroiditis. J Endocrine Soc. 2023;7(Supplement_
1):bvad114.2041.
8. Vardell Noble V, Ermann DA, Griffin EK, Silberstein
PT. Primary Thyroid Lymphoma: An Analysis
of the National Cancer Database. Cureus.
2019;11(4):e4088. 9. Lim H, Devesa SS, Sosa JA, Check D, Kitahara
CM. Trends in thyroid cancer incidence and
mortality in the United States, 1974-2013. JAMA.
2017;317(13):1338-1348.
10. Hsi ED, Singleton TP, Svoboda SM, Schnitzer
B, Ross CW. Characterization of the
Lymphoid Infiltrate in Hashimoto Thyroiditis
by Immunohistochemistry and Polymerase
Chain Reaction for Immunoglobulin Heavy
Chain Gene Rearrangement. Am J Clin Pathol.
1998;110(3):327-333.
11. Al-Mansour M, Maglan AF, Altayeb MK, et al.
The Risk of Developing Lymphoma among
Autoimmune Thyroid Disorder Patients: A Cross-
Section Study. Dis Markers. 2022;2022:4354595.
12. Foppiani L, Secondo V, Arlandini A, Quilici P, Cabria
M, Del Monte P. Thyroid lymphoma: a rare tumor
requiring combined management. Hormones
(Athens). 2009;8(3):214-218.
13. Sato Y, Nakamura N, Nakamura S, et al. Deviated
VH4 immunoglobulin gene usage is found
among thyroid mucosa-associated lymphoid
tissue lymphomas, similar to the usage at other
sites, but is not found in thyroid diffuse large
B-cell lymphomas. Mod Pathol. 2006;19(12):1578-
1584.
14. Walsh S, Lowery AJ, Evoy D, McDermott
EW, Prichard RS. Thyroid lymphoma: recent
advances in diagnosis and optimal management
strategies. Oncologist. 2013;18(9):994-1003.
15. Stein SA, Wartofsky L. Primary thyroid lymphoma:
a clinical review. J Clin Endocrinol Metab.
2013;98(8):3131-3138.
16. Wang D, Du LY, Sun JW, et al. Evaluation of
thyroid nodules with coexistent Hashimoto's
thyroiditis according to various ultrasoundbased
risk stratification systems: A retrospective
research. Eur J Radiol. 2020;131:109059. [17]
Vander Poorten V, Goedseels N, Triantafyllou A,
et al. Effectiveness of core needle biopsy in the
diagnosis of thyroid lymphoma and anaplastic
thyroid carcinoma: a systematic review and
meta-analysis. Front Endocrinol (Lausanne).
2022;13:971249.
17. Sippel RS, Gauger PG, Angelos P, Thompson NW,
Mack E, Chen H. Palliative thyroidectomy for
malignant lymphoma of the thyroid. Ann Surg
Oncol. 2002;9(9):907-911.
18. Howlader N, Noone AM, Krapcho M, et al. SEER
Cancer Statistics Review, 1975-2017. National
Cancer Institute. 2019.
19. Hyjek E, Isaacson PG. Primary B cell lymphoma of
the thyroid and its relationship to Hashimoto's
thyroiditis. Hum Pathol. 1988;19(11):1315-1326.
[21] Sun M, Qu H, Xia H, et al. Implications
of a Ultrasomics Signature for Predicting
Malignancy in Thyroid Nodules with Hashimoto's
Thyroiditis. Acad Radiol. 2024;31(11):4386-4395.
20. Radzina M, Ratniece M, Putrins DS, et al.
Performance of contrast-enhanced ultrasound in
thyroid nodules: review of current state and future
perspectives. Cancers (Basel). 2021;13(21):5469.
21. Hwang YC, Kim TY, Kim WB, et al. Clinical
characteristics of primary thyroid lymphoma in
Koreans. Endocr J. 2009;56(3):399-405.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain copyright and grant the Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD) the right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
© Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD). Published by the Indonesian Society of Endocrinology (PERKENI).


